Duoning Biotechnology, a Chinese biotech firm that focuses on providing serum-free cell culture medium, has raised nearly RMB100 million (US$14.88 million) in a series A+ round of financing, according to a statement released on Thursday. Investors of this round include healthcare-focused Chinese private equity firm Ally Bridge Group and an industry fund managed by Hong […]

Chinese Biotech Firm Duoning Biotechnology Closes Nearly $15M Series A+ Round comes originally from China Money Network. All Rights Reserved.